TAC1 and brain ischemia: After the onset of cerebral ischemia, endogenous Na+/K+-ATPase (NKA) inhibitors that damaged the innate NKA activity were released to the peripheral circulation (54), leading to ATP depletion, which in turn exacerbated anoxic damage (55, 56).